%PDF-1.5
%
1 0 obj
<<
/Lang (en)
/MarkInfo <<
/Marked true
>>
/Metadata 2 0 R
/Outlines 3 0 R
/PageLayout /OneColumn
/PageMode /UseOutlines
/Pages 4 0 R
/StructTreeRoot 5 0 R
/Type /Catalog
/ViewerPreferences <<
/DisplayDocTitle true
>>
>>
endobj
6 0 obj
<<
/Author (Gemeinsamer Bundesausschuss/Federal Joint Committee \(g-ba.de\))
/Category ()
/Comments ()
/Company ()
/CreationDate (D:20221115133225+01'00')
/Creator <4163726F626174205044464D616B65722031352066FC7220576F7264>
/Keywords <416E6E6578205849492085205265736F6C7574696F6E73206F6E207468652042656E65666974204173736573736D656E74206F66204D65646963696E616C2050726F64756374732077697468204E65772041637469766520496E6772656469656E7473204163636F7264696E6720746F2053656374696F6E2033356120534742205620202D204D65706F6C697A756D6162>
/Manager ()
/ModDate (D:20221124100515+01'00')
/Producer (Adobe PDF Library 15.0)
/SourceModified (D:20221115123220)
/Subject (Pharmaceuticals Directive \(AM RL\):)
/Title (Resolution)
/_DocHome (1460877555)
>>
endobj
2 0 obj
<<
/Length 4913
/Subtype /XML
/Type /Metadata
>>
stream
2022-11-24T10:05:15+01:00
2022-11-15T13:32:25+01:00
2022-11-24T10:05:15+01:00
Acrobat PDFMaker 15 für Word
uuid:a273da13-52b9-4571-9b77-359924af58f7
uuid:b412a606-cc40-46cf-adca-a6b574cc0ccf
1
application/pdf
Resolution
Pharmaceuticals Directive (AM RL):
Gemeinsamer Bundesausschuss/Federal Joint Committee (g-ba.de)
Annex XII – Resolutions on the Benefit Assessment of Medicinal Products with New Active Ingredients According to Section 35a SGB V
- Mepolizumab
Adobe PDF Library 15.0
Annex XII – Resolutions on the Benefit Assessment of Medicinal Products with New Active Ingredients According to Section 35a SGB V - Mepolizumab
D:20221115123220
1460877555
Arzneimittel-Richtlinie: Anlage XII â•fi Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach § 35a SGB V
endstream
endobj
3 0 obj
<<
/Count 4
/First 7 0 R
/Last 8 0 R
/Type /Outlines
>>
endobj
4 0 obj
<<
/Count 3
/Kids [9 0 R 10 0 R 11 0 R]
/Type /Pages
>>
endobj
5 0 obj
<<
/K 12 0 R
/ParentTree 13 0 R
/ParentTreeNextKey 6
/RoleMap 14 0 R
/Type /StructTreeRoot
>>
endobj
7 0 obj
<<
/A 15 0 R
/Next 16 0 R
/Parent 3 0 R
/Title (1. Additional benefit of the medicinal product in relation to the appropriate comparator therapy)
>>
endobj
8 0 obj
<<
/A 17 0 R
/Parent 3 0 R
/Prev 18 0 R
/Title (4. Treatment costs)
>>
endobj
9 0 obj
<<
/Annots [19 0 R]
/Contents [20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 29 0 R]
/CS1 [/ICCBased 30 0 R]
>>
/Font <<
/TT0 31 0 R
/TT1 32 0 R
/TT2 33 0 R
/TT3 34 0 R
/TT4 35 0 R
>>
/XObject <<
/OL1 36 0 R
>>
>>
/Rotate 0
/StructParents 0
/Tabs /S
/Type /Page
>>
endobj
10 0 obj
<<
/Annots [37 0 R 38 0 R]
/Contents [39 0 R 40 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 29 0 R]
/CS1 [/ICCBased 30 0 R]
>>
/Font <<
/C2_0 41 0 R
/C2_1 42 0 R
/TT0 31 0 R
/TT1 32 0 R
/TT2 34 0 R
>>
/XObject <<
/OL1 36 0 R
>>
>>
/Rotate 0
/StructParents 1
/Tabs /S
/Type /Page
>>
endobj
11 0 obj
<<
/Contents [43 0 R 44 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 29 0 R]
>>
/Font <<
/TT0 31 0 R
>>
/XObject <<
/OL1 36 0 R
>>
>>
/Rotate 0
/StructParents 4
/Tabs /S
/Type /Page
>>
endobj
12 0 obj
<<
/K [45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R
55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R
65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R
75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R
85 0 R 86 0 R]
/P 5 0 R
/S /Sect
>>
endobj
13 0 obj
<<
/Nums [0 [45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R
55 0 R 56 0 R 57 0 R 58 0 R null null null null 87 0 R null
null null null 60 0 R 61 0 R 62 0 R 64 0 R 65 0 R 66 0 R 67 0 R
68 0 R null 88 0 R null 89 0 R null null 90 0 R null 91 0 R
null 92 0 R null null 93 0 R null 94 0 R null 95 0 R null
96 0 R null 97 0 R 62 0 R]
1 [null 98 0 R null 99 0 R 100 0 R 101 0 R null 102 0 R null 103 0 R
104 0 R 105 0 R null 106 0 R null 107 0 R 108 0 R 109 0 R null 110 0 R
null 111 0 R 112 0 R 113 0 R null 114 0 R null 115 0 R null 116 0 R
null 117 0 R null 118 0 R null 119 0 R null 120 0 R null 121 0 R
null 122 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R null 123 0 R 75 0 R
76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R null 124 0 R null 125 0 R
null null 126 0 R null 127 0 R null 128 0 R null 129 0 R null
130 0 R null 131 0 R null 132 0 R null 133 0 R 134 0 R]
2 123 0 R 3 123 0 R 4 [null 135 0 R null 136 0 R null null 137 0 R null 138 0 R null
139 0 R null 140 0 R null 141 0 R 142 0 R null 143 0 R null 144 0 R
145 0 R null 146 0 R null 147 0 R null 148 0 R null 149 0 R null
150 0 R 151 0 R null 152 0 R null 153 0 R 154 0 R null 155 0 R null
156 0 R 157 0 R null 158 0 R null 159 0 R 160 0 R null 161 0 R null
162 0 R 163 0 R null 164 0 R null 165 0 R 166 0 R 83 0 R 84 0 R 85 0 R
86 0 R]
5 97 0 R]
>>
endobj
14 0 obj
<<
/Annotation /Span
/Artifact /P
/Bibliography /BibEntry
/Chart /Figure
/Diagram /Figure
/DropCap /Figure
/Endnote /Note
/Footnote /Note
/InlineShape /Figure
/Outline /Span
/Strikeout /Span
/Subscript /Span
/Superscript /Span
/TextBox /Art
/Underline /Span
>>
endobj
15 0 obj
<<
/D [9 0 R /XYZ 69 509 0.0]
/S /GoTo
>>
endobj
16 0 obj
<<
/A 167 0 R
/Next 18 0 R
/Parent 3 0 R
/Prev 7 0 R
/Title (2. Number of patients or demarcation of patient groups eligible for treatment)
>>
endobj
17 0 obj
<<
/D [10 0 R /XYZ 69 229 0.0]
/S /GoTo
>>
endobj
18 0 obj
<<
/A 168 0 R
/Next 8 0 R
/Parent 3 0 R
/Prev 16 0 R
/Title (3. Requirements for a quality-assured application)
>>
endobj
19 0 obj
<<
/A 169 0 R
/BS <<
/S /S
/Type /Border
/W 0
>>
/Border [0 0 0]
/F 4
/H /I
/Rect [253.08 258.074 257.156 269.234]
/StructParent 5
/Subtype /Link
/Type /Annot
>>
endobj
20 0 obj
<<
/Length 37
/Filter /FlateDecode
>>
stream
x+*23P0bdBr.KB W
endstream
endobj
21 0 obj
<<
/Length 1068
/Filter /FlateDecode
>>
stream
HVMo7ϯYQ qzAn68[}6(=(j$RO$Wۃxyu8\o?>ͻyRkݒC[ŷzy'wvyg>˗W?˄8}9\~KPo[WQۻ)UM&a7hmXQZqz+!֥s
MԸrqݙ/TG/Os9x!vKqKC^)E1bD]v[ Pvk=Ɓn5CǶC5p3>t
+}+P2\XJg*"$l[lKb%){s!S0Xr!%" R\i$ '(lҜT5J=Ps;m.+@xWi 1-р?'ác4-SϵHi~siGT|ߕtu;v
m<CmIa\Fx@n~<4:LhhO0܇,[PS7~̳K@*{99.%0@EtɦPfw,9*'= PfU<]
N
יU5qa0!KhYo!u iL{U{`I j`'/+ly
,ݿo1h1?bg(HhG;?l/DҏCS V
endstream
endobj
22 0 obj
<<
/Length 1087
/Filter /FlateDecode
>>
stream
HVIn$7+I&0 0HsdP$dURy*\nlw~\-'J-s_+PlyoegV7pJZ
-ʶ:bjvx.l٭u[ײU4kzޮ]RVy
|@IgP@iBjtf_ 妕!/X$x%
7c0 ljqz%~)3Zk|.hw CtJgFGO\̂G6P2BzWNcy!#9]$ HAՠRge|]IS6}F
i۔6&-;0f͟vl*;J3ð.@jm ئ^}+ja@Z5w(Fz"dA]%!ȕyݷM'㗴
.Q3[(1[kJ]),kĤrRC!)r8?В蓼Mz:C%BExUi|P'ěZf+9NB:\ؐJS:oUqFUo[7}{{ if5i te*Pzqȳx'ej$^& ?kyTPcM`- !Y+`N^РemYV8HMu`6i)5O5҄4<
"3lӁ-dF7hs
?ʾhL"8v10E{Jv%1Ǵ-@XjXX]e`jvS U(66@3/L0LT8¨GqSŴIv FIzHW]Rzn1[ذc,W,2e=u:Dž((okgBeA>8cc0V^V>fOTN? g
endstream
endobj
23 0 obj
<<
/Length 813
/Filter /FlateDecode
>>
stream
HMn1s
^`\Q @S 誷{xi1<~')Oˏ>/K:$* 5C_Iw_(ȯEv6k/&kFK:qYz8?k)UJ£MTU&e5
eENp ˘>pp5/kf7X
"MgV7kǖ|}Ph@mؠ
k*t<7eq\Fxp錽m5BV?Fp;'64)˩̼s*=_r#cAhҐ1mun ;
^">v6ux SyX+1")!pH1<D8]q?HiW2T-le--ڍ?j9e-Y)-ܳ O}ukoG;25q)Q2fC&%k^fjXʳs?{Ვr;:b4iT6U9IV7Bu>@h
>.&w0'`ɏĢO3۳qgIf[gAǏXbi{r)x
@᧥wWpRhsy2ZIBoLNA\w2:jT3*B$vu2D1sNt=nWnj;
xj:`$Dj?s%Pd)Iy,ߗ2ȁ>gNuծc^,R](5lYס|6X# BZ
endstream
endobj
24 0 obj
<<
/Length 1140
/Filter /FlateDecode
>>
stream
HKoFwI.p @l@pb/ZU4KQ]ђ|sΙPJt|&Mno(hM̙>ڛM"R[ِqTd'euaEQBc?
]s^Uq[ks:/nduGRfpðr1Of
ѐz.SVfM)0D\;ɅXk:[&xʅLf89nC0):hQ-]CVD<ђTȈll8=UR>ad,@k
a
紑iǴ{'P"%!%f =r3Nƌ{f\3 A@
9Kȓ1}n3̢9hzGPme[(l
FO8s`'^`
*0-rfr7PǕ!-la9$qQsoP? ;&;fo?2?h+sȊ6=Qνۗm }A Jq9 jx6瓍Myス7`QSb+yajBގ ,27T6Þ3gXvzVg8sCcl>GKIaJײ4%U%I/qvC-ڧ.v]b7ck|Cdys͈A۸ݾ}~